Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules

D. Chester Kalter, Howard E. Gendelman, Monte S. Meltzer

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

CD4 is the surface receptor for HIV envelope. Some evidence exists, however, that other cell surface receptors may be involved in viral entry subsequent to the initial binding of gp120 to CD4. Antibodies to leukocyte integrin LFA-1, a major component of intercellular adhesive interactions, have been shown to inhibit HIV-induced syncytia formation. Using a stringent system for in vitro HIV infection of human leukocytes, we examine the ability of some monoclonal antibodies (mAb) against various adhesion-related molecules to block or partially inhibit productive viral replication. HIV-1 infection of target monocytes or T cells by cell-free virus was blocked completely or partially by some mAb that prevent cell-cell interactions (CD4, HLA-DR, LFA-1, LFA-3), but not by others (ICAM-1, MAC-1, gp150.95, CD2, CD3, CD14). The capacity for mAb to block HIV infection appears to be epitope-specific, and does not relate to the ability to block homotypic adhesion. HIV transmission from infected cells was more difficult to block than was infection by cell-free virus. Adhesion molecules may be involved in facilitating early stages of HIV infection, following gp120/CD4 binding but prior to viral integration, in a manner distinct from cell-cell adhesion.

Original languageEnglish (US)
Pages (from-to)219-227
Number of pages9
JournalImmunology Letters
Volume30
Issue number2
DOIs
StatePublished - Oct 1991

Fingerprint

Cell Adhesion Molecules
Virus Diseases
Monocytes
Monoclonal Antibodies
HIV
HIV Infections
Lymphocyte Function-Associated Antigen-1
Leukocytes
CD58 Antigens
Virus Integration
Viruses
CD4 Antigens
Cell Surface Receptors
HLA-DR Antigens
Giant Cells
Intercellular Adhesion Molecule-1
Cell Adhesion
Integrins
Cell Communication
Adhesives

Keywords

  • HIV
  • Inhibition of infection
  • Leukocyte adhesion molecule
  • Monocyte

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules. / Chester Kalter, D.; Gendelman, Howard E.; Meltzer, Monte S.

In: Immunology Letters, Vol. 30, No. 2, 10.1991, p. 219-227.

Research output: Contribution to journalArticle

@article{38f19d28a8cc41a78c0f8e92858d302a,
title = "Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules",
abstract = "CD4 is the surface receptor for HIV envelope. Some evidence exists, however, that other cell surface receptors may be involved in viral entry subsequent to the initial binding of gp120 to CD4. Antibodies to leukocyte integrin LFA-1, a major component of intercellular adhesive interactions, have been shown to inhibit HIV-induced syncytia formation. Using a stringent system for in vitro HIV infection of human leukocytes, we examine the ability of some monoclonal antibodies (mAb) against various adhesion-related molecules to block or partially inhibit productive viral replication. HIV-1 infection of target monocytes or T cells by cell-free virus was blocked completely or partially by some mAb that prevent cell-cell interactions (CD4, HLA-DR, LFA-1, LFA-3), but not by others (ICAM-1, MAC-1, gp150.95, CD2, CD3, CD14). The capacity for mAb to block HIV infection appears to be epitope-specific, and does not relate to the ability to block homotypic adhesion. HIV transmission from infected cells was more difficult to block than was infection by cell-free virus. Adhesion molecules may be involved in facilitating early stages of HIV infection, following gp120/CD4 binding but prior to viral integration, in a manner distinct from cell-cell adhesion.",
keywords = "HIV, Inhibition of infection, Leukocyte adhesion molecule, Monocyte",
author = "{Chester Kalter}, D. and Gendelman, {Howard E.} and Meltzer, {Monte S.}",
year = "1991",
month = "10",
doi = "10.1016/0165-2478(91)90029-A",
language = "English (US)",
volume = "30",
pages = "219--227",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Inhibition of human immunodeficiency virus infection in monocytes by monoclonal antibodies against leukocyte adhesion molecules

AU - Chester Kalter, D.

AU - Gendelman, Howard E.

AU - Meltzer, Monte S.

PY - 1991/10

Y1 - 1991/10

N2 - CD4 is the surface receptor for HIV envelope. Some evidence exists, however, that other cell surface receptors may be involved in viral entry subsequent to the initial binding of gp120 to CD4. Antibodies to leukocyte integrin LFA-1, a major component of intercellular adhesive interactions, have been shown to inhibit HIV-induced syncytia formation. Using a stringent system for in vitro HIV infection of human leukocytes, we examine the ability of some monoclonal antibodies (mAb) against various adhesion-related molecules to block or partially inhibit productive viral replication. HIV-1 infection of target monocytes or T cells by cell-free virus was blocked completely or partially by some mAb that prevent cell-cell interactions (CD4, HLA-DR, LFA-1, LFA-3), but not by others (ICAM-1, MAC-1, gp150.95, CD2, CD3, CD14). The capacity for mAb to block HIV infection appears to be epitope-specific, and does not relate to the ability to block homotypic adhesion. HIV transmission from infected cells was more difficult to block than was infection by cell-free virus. Adhesion molecules may be involved in facilitating early stages of HIV infection, following gp120/CD4 binding but prior to viral integration, in a manner distinct from cell-cell adhesion.

AB - CD4 is the surface receptor for HIV envelope. Some evidence exists, however, that other cell surface receptors may be involved in viral entry subsequent to the initial binding of gp120 to CD4. Antibodies to leukocyte integrin LFA-1, a major component of intercellular adhesive interactions, have been shown to inhibit HIV-induced syncytia formation. Using a stringent system for in vitro HIV infection of human leukocytes, we examine the ability of some monoclonal antibodies (mAb) against various adhesion-related molecules to block or partially inhibit productive viral replication. HIV-1 infection of target monocytes or T cells by cell-free virus was blocked completely or partially by some mAb that prevent cell-cell interactions (CD4, HLA-DR, LFA-1, LFA-3), but not by others (ICAM-1, MAC-1, gp150.95, CD2, CD3, CD14). The capacity for mAb to block HIV infection appears to be epitope-specific, and does not relate to the ability to block homotypic adhesion. HIV transmission from infected cells was more difficult to block than was infection by cell-free virus. Adhesion molecules may be involved in facilitating early stages of HIV infection, following gp120/CD4 binding but prior to viral integration, in a manner distinct from cell-cell adhesion.

KW - HIV

KW - Inhibition of infection

KW - Leukocyte adhesion molecule

KW - Monocyte

UR - http://www.scopus.com/inward/record.url?scp=0026000541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026000541&partnerID=8YFLogxK

U2 - 10.1016/0165-2478(91)90029-A

DO - 10.1016/0165-2478(91)90029-A

M3 - Article

C2 - 1757107

AN - SCOPUS:0026000541

VL - 30

SP - 219

EP - 227

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 2

ER -